Public calls
Every call the briefs have made in public, with the odds each edition printed and how it turned out, misses included.
From the editions you can open: each brief's latest, and back issues of the briefs you subscribe to. Odds and status are shown as printed.
Open · 3
-
FDA approves BridgeBio’s BBP-418 for limb-girdle muscular dystrophy 2I/R9
Odds now60%As printed: “Open” · Biotech & Pharma · No. 052 ·
-
CMS publishes negotiated maximum fair prices for the 15 drugs selected for 2028
Odds now90%As printed: “Open” · Biotech & Pharma · No. 052 ·
-
A biopharma acquisition of $5B or more is announced
Odds now80%As printed: “Open” · Biotech & Pharma · No. 052 ·
Resolved · 0
No resolved calls in the editions you can open.